Launched at the American Organization of Nurse Executives annual tradeshow in April, Firefly Medical’s IVEA aims to ensure safe patient handling and mobility as well as reduce the number of stress ...

Certain genetic mutations in patients with DMD influence the timing of ambulation loss, with exon 44 skipping, exons 3 through 7 deletions, and exon 2 duplications linked to delayed loss. The study's ...

Please provide your email address to receive an email when new articles are posted on . A single-stage treatment for pediatric patients with arthrogryposis improved mechanics and ambulation. The ...

Later age at loss of ambulation (LOA) in DMD patients is linked to better LVEF preservation in adulthood. Prolonging ambulation does not adversely affect long-term cardiac function, even when ...

A positive effect of nusinersen treatment on motor function in ambulant pediatric and adult spinal muscular atrophy (SMA) patients during a 38-month period has been demonstrated by an analysis of data ...